Dr. Jyoti S. Mayadev, MD

Dr. Mayadev practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Mayadev's NPI, 1902906902, was assigned on September 22, 2006. Dr. Mayadev graduated from Cleveland Medical College, Homeopathic in 2004. Dr. Mayadev's California license number on file is A109372.

Dr. Mayadev's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Mayadev's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Mayadev is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mayadev practices. Vendor and product names are available with a free account.

Radiation oncology is Dr. Mayadev's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Mayadev is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Mayadev's licenses on file in 3 states: California, Oregon and Washington.

Dmand AI lists breast cancer radiation, cervical cancer radiation, lung cancer radiation, prostate cancer radiation and uterine cancer radiation among the conditions Dr. Mayadev treats.

CMS data shows 307 Medicare services from Dr. Mayadev across 6 procedure codes in 2024, for 174 Medicare patients. Medicare paid $17,571 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 174 Medicare patients who saw Dr. Mayadev in 2024. The largest group is 65 to 74, with 100 patients. 72% of them have cancer, and 71% have high blood pressure. 26% are also on Medicaid. Their average risk score is 1.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mayadev's median patient age at 64, with 70% women.

In 2024, Dr. Mayadev wrote 12 Medicare Part D claims. 100% of them were for generic drugs. They cover 1 drug, with $566 in total drug cost. In 2021, CMS named 15 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Mayadev for performance year 2024, reported as part of a group. Dr. Mayadev accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mayadev as offering telehealth.

Dmand AI links 105 papers to Dr. Mayadev, published from 2011 to 2025. 2020 was the busiest year, with 12. The most frequent topics are Uterine Cervical Neoplasms, Brachytherapy and Radiotherapy Dosage. Dr. Mayadev has published most often in Brachytherapy. Dr. Mayadev's most frequent co-authors are Loren K. Mell, MD, Catheryn M. Yashar, MD and Richard K. Valicenti, MD.

Dmand AI links Dr. Mayadev to 6 clinical trials, 2 of them phase 1 studies. 3 are still active or recruiting. Conditions studied include Breast Neoplasms, Uterine Cervical Neoplasms and Breast Diseases. National Cancer Institute (NCI) sponsors the most, 3.

CMS Open Payments shows 102 general payments to Dr. Mayadev from 15 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 71% of the total. Siemens Medical Solutions USA, Inc. paid the most, $61,599.

Dmand AI lists 1 award for Dr. Mayadev, most recently CMS Stage 1 EHR in 2012.

Dr. Mayadev graduated from Cleveland Medical College, Homeopathic in 2004.

Dr. Mayadev is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.